Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAPT Antikörper (Middle Region)

MAPT Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN634593
  • Target Alle MAPT Antikörper anzeigen
    MAPT (Microtubule-Associated Protein tau (MAPT))
    Bindungsspezifität
    • 11
    • 9
    • 9
    • 8
    • 7
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reaktivität
    • 214
    • 110
    • 100
    • 15
    • 12
    • 8
    • 7
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 201
    • 18
    • 6
    Kaninchen
    Klonalität
    • 195
    • 30
    Polyklonal
    Konjugat
    • 179
    • 17
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Dieser MAPT Antikörper ist unkonjugiert
    Applikation
    • 195
    • 119
    • 61
    • 36
    • 25
    • 21
    • 14
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB)
    Spezifität
    MAPT antibody was raised against the middle region of MAPT
    Aufreinigung
    Affinity purified
    Immunogen
    MAPT antibody was raised using the middle region of MAPT corresponding to a region with amino acids NAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLAD
    Top Product
    Discover our top product MAPT Primärantikörper
  • Applikationshinweise
    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    MAPT Blocking Peptide, catalog no. 33R-6638, is also available for use as a blocking control in assays to test for specificity of this MAPT antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MAPT antibody in PBS
    Konzentration
    Lot specific
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target
    MAPT (Microtubule-Associated Protein tau (MAPT))
    Andere Bezeichnung
    MAPT (MAPT Produkte)
    Synonyme
    DDPAC antikoerper, FTDP-17 antikoerper, MAPTL antikoerper, MSTD antikoerper, MTBT1 antikoerper, MTBT2 antikoerper, PPND antikoerper, TAU antikoerper, AI413597 antikoerper, AW045860 antikoerper, Mtapt antikoerper, Tau antikoerper, RNPTAU antikoerper, pTau antikoerper, tau antikoerper, xtp antikoerper, MAPT antikoerper, PHF-tau antikoerper, slc6a6 antikoerper, taut antikoerper, wu:fc26e12 antikoerper, microtubule associated protein tau antikoerper, microtubule-associated protein tau antikoerper, microtubule associated protein tau S homeolog antikoerper, Microtubule-associated protein tau antikoerper, solute carrier family 6 (neurotransmitter transporter), member 6b antikoerper, MAPT antikoerper, Mapt antikoerper, mapt.S antikoerper, LOC5580230 antikoerper, CpipJ_CPIJ013260 antikoerper, tau antikoerper, slc6a6b antikoerper
    Hintergrund
    MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
    Molekulargewicht
    40 kDa (MW of target protein)
    Pathways
    MAPK Signalweg, Microtubule Dynamics, M Phase, Regulation of Cell Size
Sie sind hier:
Kundenservice